Pramipexole - Latest Advances

In brief: Adjunctive pramipexole for treatment-resistant depression.

Journal: The Medical letter on drugs and therapeutics

Published: October 08, 2025

On the mechanisms of dopamine receptor agonists in restless legs syndrome.

Journal: Sleep

Published: August 07, 2025

Genetic changes in regulatory immune cells induced by pramipexole and rotigotine: implications for the treatment of Parkinson's disease.

Journal: Inflammopharmacology

Published: August 04, 2025

Restless Eyes at Night: A Novel Variant of Restless Legs Syndrome.

Journal: European journal of case reports in internal medicine

Published: July 14, 2025

Onapgo - an apomorphine subcutaneous infusion for Parkinson's disease.

Journal: The Medical letter on drugs and therapeutics

Published: July 12, 2025

Pramipexole improves cognitive deficits and synaptic plasticity impairments in 3xTg-AD mice through enhancing autophagy.

Journal: Experimental neurology

Published: June 27, 2025

Biased Signaling Agonists of Dopamine D3 Receptor Differentially Regulate the Effects of Cocaine On Dopamine Transporter Function.

Journal: ACS chemical neuroscience

Published: June 26, 2025

Dopamine Agonist Pramipexole Halts Leflunomide Nephrotoxicity: A Dual Strike on TLR4-Driven Inflammation and PI3K/Akt Suppression.

Journal: European journal of pharmacology

Published: June 06, 2025

Late-Onset Oral Cenesthopathy With Dopaminergic Dysfunction: Therapeutic Response to Pramipexole in a Case With Suspected Prodromal Lewy Body Disease.

Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

Published: June 05, 2025

Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.

Journal: Health technology assessment (Winchester, England)

Published: June 02, 2025

Meta-analysis of the therapeutic effect and safety of repetitive transcranial magnetic stimulation combined with pramipexole in Parkinson's disease.

Journal: Medicine

Published: June 02, 2025

Comparative efficacy of antidepressant augmentation with amantadine vs pramipexole in treatment-resistant unipolar depression: A randomised controlled trial.

Journal: Journal of affective disorders

Published: May 20, 2025

Filters

In brief: Adjunctive pramipexole for treatment-resistant depression.

In brief: Adjunctive pramipexole for treatment-resistant depression.

On the mechanisms of dopamine receptor agonists in restless legs syndrome.

On the mechanisms of dopamine receptor agonists in restless legs syndrome.

Genetic changes in regulatory immune cells induced by pramipexole and rotigotine: implications for the treatment of Parkinson's disease.

Genetic changes in regulatory immune cells induced by pramipexole and rotigotine: implications for the treatment of Parkinson's disease.

Restless Eyes at Night: A Novel Variant of Restless Legs Syndrome.

Restless Eyes at Night: A Novel Variant of Restless Legs Syndrome.

Onapgo - an apomorphine subcutaneous infusion for Parkinson's disease.

Onapgo - an apomorphine subcutaneous infusion for Parkinson's disease.

Pramipexole improves cognitive deficits and synaptic plasticity impairments in 3xTg-AD mice through enhancing autophagy.

Pramipexole improves cognitive deficits and synaptic plasticity impairments in 3xTg-AD mice through enhancing autophagy.

Biased Signaling Agonists of Dopamine D3 Receptor Differentially Regulate the Effects of Cocaine On Dopamine Transporter Function.

Biased Signaling Agonists of Dopamine D3 Receptor Differentially Regulate the Effects of Cocaine On Dopamine Transporter Function.

Dopamine Agonist Pramipexole Halts Leflunomide Nephrotoxicity: A Dual Strike on TLR4-Driven Inflammation and PI3K/Akt Suppression.

Dopamine Agonist Pramipexole Halts Leflunomide Nephrotoxicity: A Dual Strike on TLR4-Driven Inflammation and PI3K/Akt Suppression.

Late-Onset Oral Cenesthopathy With Dopaminergic Dysfunction: Therapeutic Response to Pramipexole in a Case With Suspected Prodromal Lewy Body Disease.

Late-Onset Oral Cenesthopathy With Dopaminergic Dysfunction: Therapeutic Response to Pramipexole in a Case With Suspected Prodromal Lewy Body Disease.

Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.

Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.

Meta-analysis of the therapeutic effect and safety of repetitive transcranial magnetic stimulation combined with pramipexole in Parkinson's disease.

Meta-analysis of the therapeutic effect and safety of repetitive transcranial magnetic stimulation combined with pramipexole in Parkinson's disease.

Comparative efficacy of antidepressant augmentation with amantadine vs pramipexole in treatment-resistant unipolar depression: A randomised controlled trial.

Comparative efficacy of antidepressant augmentation with amantadine vs pramipexole in treatment-resistant unipolar depression: A randomised controlled trial.